key: cord-0928685-f5tlwwqq
authors: Kotwal, Ashwin A.; Cenzer, Irena S.; Waite, Linda J.; Smith, Alexander K.; Perissinotto, Carla M.; Hawkley, Louise C.
title: A single question assessment of loneliness in older adults during the COVID‐19 pandemic: A nationally‐representative study
date: 2022-02-12
journal: J Am Geriatr Soc
DOI: 10.1111/jgs.17700
sha: a6c12e2be1323a26f29971e5c5f03fe66325249d
doc_id: 928685
cord_uid: f5tlwwqq

nan

Loneliness is common, particularly during the COVID-19 pandemic, prompting many clinicians and researchers to assess for loneliness. [1] [2] [3] However, the best approach for screening is unclear. One option is a single question directly asking about loneliness ("how often are you lonely?"). However, concerns about sensitivity or stigma surrounding self-identifying as "lonely" have led to use of multi-item scales that avoid the term "lonely," 4 which can be time-intensive or unfamiliar to clinicians. 5 The COVID-19 pandemic presents a unique opportunity to revisit the use of the single loneliness question for two reasons. First, societal perceptions of identifying as "lonely" may have changed due to social restrictions, making it a common experience more openly discussed. Second, national surveys now (a) include both single direct loneliness questions and longer scales, and (b) have similar administration protocols for each assessment, making comparisons of performance more feasible. If the single question performs similarly to longer scales, it could reduce barriers to loneliness assessments in clinical and research settings. Our objective was therefore to compare the relationship between the single question and scale loneliness assessments in COVID-19 and prepandemic samples.

We used the nationally-representative National Social Life Health and Aging Project (NSHAP), including participants interviewed in Round 3 (R3) (2015-2016), and reinterviewed in the COVID-19 supplement (September 14, 2020-January 27, 2021) (conditional response rate: 58%), yielding a sample of 2168 community-dwelling older adults. 6 Loneliness was measured using a single direct question ("how often do you feel lonely") and the gold-standard 3-item UCLA Loneliness scale (range: 3-9 points) at both study time points. 7 There were notable differences in administration of each assessment in prepandemic data which were resolved in COVID-19 data (described in Table S1 ). For the single loneliness assessment, we categorized responses of "some of the time" or higher as indicating loneliness based on prior literature and consistency of this category between waves. 8, 9 Demographic and health measures included age, gender, marital status, education, depression, self-reported happiness, and self-reported health.

We first re-established the optimal cut-point to translate between the single question and the UCLA scale (range: 3-9 points) using receiver operating characteristic (ROC) curves, 4 and computed the area under the curve (AUC), a global measure of test discrimination. We prioritized a cut-point minimizing false negatives as more harm might arise in a clinical setting from failing to identify individuals as lonely. We then examined the bivariate associations of the single question and the UCLA scale with demographic and health measures to demonstrate construct validity and whether different sub-groups responded differently to each assessment. Analyses were stratified by the time of data collection (2015-2016 vs. COVID-19) and made use of provided sample weights.

At baseline, participants were on average 63.9 years old (SD = 8.8, 50-64: 55%, 65-74: 32%, 75-84: 11%, 85-94: 2%), 56% female, 71% married, 9% Black/African American, and 6% Hispanic, Non-White. There was an increase in loneliness from pre-pandemic to COVID-19 data for both loneliness assessments (single question: 28%-32%, p-value = 0.007; UCLA scale: 18%-21%, p-value = 0.03). ROC curves demonstrated the positive response on the single question corresponded most optimally with a cutpoint of ≥6 points on the UCLA scale, and that the AUC was higher in the COVID-19 data (AUC = 0.908, 95% CI: 0.89-0.92) compared with the pre-pandemic data (AUC = 0.751, 95% CI: 0.73-0.77, Figure 1 ). The single question had 90% sensitivity and 83% specificity for identifying individuals scoring ≥6 points on the UCLA scale, with a lower rate of false negatives in COVID-19 data compared to pre-pandemic data (3% vs. 10%; Table S2 ). Loneliness differed by education level when using the single question, but did not differ when using the UCLA scale (p-value for difference = 0.02) ( Table 1) . Health measures, including depression, happiness, and self-rated health, were strongly correlated with both loneliness assessments at a similar magnitude.

In a nationally-representative sample of communitydwelling older adults, the single question "how often are you lonely?" was sufficient to classify individuals as lonely during the COVID-19 pandemic. The single question misclassified only 3% of those identified as lonely by the longer measure. Notably, both measures were strongly, and similarly associated with mental health, including depression, happiness, and self-rated health, suggesting strong construct validity of the single question and that both assessments can provide important clinical insight into psychological well-being. The substantially stronger association between the single question and 3-item UCLA scale during than before the pandemic may be attributable to (1) normalization and reduced stigma of identifying as lonely, and (2) the use of identical administration protocols for the two assessment types during the pandemic in contrast to substantial differences in prior rounds of NSHAP and other national surveys (see Table S1 ). 4 Taken together, while longer scales remain appropriate for comprehensive assessments of loneliness, results suggest a single question is a reasonable candidate to reduce barriers to screening in time-limited surveys or clinical settings, and could be incorporated into comprehensive, multidomain assessments of the social determinants of health. Results are generalizable to community-dwelling adults without severe cognitive impairment, age 50 or older. An important limitation is that NSHAP respondents were relatively anonymous, in contrast to clinical settings where individuals are not de-identified; stigma and sensitivity may consequently still play a role in false negative responses to the single question. Future work in diverse clinical settings can determine if the single question loneliness assessment performs similarly to these survey results.

All authors report no conflicts of interest. 

The sponsor had no role in the design, methods, data collection, analysis, or preparation of the paper.

Additional supporting information may be found in the online version of the article at the publisher's website. 

The direct impact of COVID-19 on nursing home and assisted living facility residents in the United States has been devastating. Since the start of the pandemic, roughly 1-in-12 residents in these facilities have died from COVID-19, a toll that represents around 35% of all COVID-19 deaths nationally. 1 Beyond these staggering figures, the indirect effects of COVID-19 on these individuals and the care they received are not yet fully understood. One important indicator of how nursing homes and assisted living facilities have adapted to COVID clinically is in how medication use has changed. Prescribing can be an early signal of potentially inappropriate care and/or of a changing patient population. Our study focuses on prescribing of select psychotropic and pain medications. Nursing home prescribing for these medications has attracted scrutiny, and the potential is high for negative health consequences among older residents, many of whom have dementia and severe pain. [2] [3] [4] [5] 

We used pharmacy claims from IQVIA's Community LRx and LTC-LRx products, respectively capturing around 95% of retail and 75% of nursing home/assisted living claims (our data do not include facility identifiers or distinguish between facility types), regardless of payer. We focus on individuals 65 years and older with LTC LRx claims (roughly 400,000 each month), generally comparing medication use before and after March 2020 (Table S1 ). We focused on the following medication categories: antipsychotics; benzodiazepines; antidepressants; opioids; muscle relaxants; and mood stabilizers (Table S2) .

Analyses examined, by month, the proportion of: i) individuals with any use; ii) individuals who initiated use; and iii) newly admitted individuals who initiated use. For outcome ii, we identified the proportion of stays with a prescription fill among stays that began 31 days or more previously and did not have use of that medication in the previous 30 days. For outcome iii, we analyzed the proportion of newly admitted individuals with a new fill and no use in the 30 days prior to the admission date.

Across our medications of interest, the prevalence and initiation of use among individuals in nursing homes

Social isolation and loneliness among San Francisco Bay Area older adults during the COVID-19 shelter-in-place orders

Loneliness, sadness, and feelings of social disconnection in older adults during the COVID-19 pandemic

Can remote social contact replace in-person contact to protect mental health among older adults?

Use of direct versus indirect approaches to measure loneliness in later life

A practical approach to assessing and mitigating loneliness and isolation in older adults

Aging Project (NSHAP); 2021

A short scale for measuring loneliness in large surveys: results from two population-based studies

Loneliness in older persons: a predictor of functional decline and death

COVID-19 social distancing measures and loneliness among older adults